FEMA550392

Influenza A H1N1 HA (A/California/07/2009) Recombinant Rabbit Monoclonal Antibody (HL2130), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 FEMA550392-Each-of-1 In Stock ₹ 41,385.00

FEMA550392 - Each of 1

₹ 41,385.00

In Stock

Quantity

1

Base Price: ₹ 41,385.00

GST (18%): ₹ 7,449.30

Total Price: ₹ 48,834.30

Antigen

Influenza A H1N1 HA (A/California/07/2009)

Classification

Recombinant Monoclonal

Concentration

1 mg/mL

Formulation

PBS with no preservative

Host Species

Rabbit

Purification Method

Protein A

Regulatory Status

RUO

Target Species

Virus

Form

Liquid

Applications

Immunocytochemistry, Western Blot

Clone

HL2130

Conjugate

Unconjugated

Gene Alias

flu hemagglutinin, H1N1 HA, H1N1 hemagglutinin, Influenza H1N1, influenza hemagglutinin

Immunogen

Recombinant fragment of Influenza A virus NS1 (nonstructural protein).

Quantity

100 μL

Primary or Secondary

Primary

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Isotype

IgG

Related Products

Img

Thermo Scientific

FEMA550352

--

Img

Thermo Scientific

FEMA550311

--

Img

Thermo Scientific

FEMA550377

--

Img

Thermo Scientific

FEMA550547

--

Img

Thermo Scientific

FEMA550330

--

Img

Thermo Scientific

FEMA550405

--

Img

Thermo Scientific

FEMA550546

--

Img

Thermo Scientific

FEMA550501

--

Description

  • Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA
  • In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States
  • The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic
  • Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins
  • The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release
  • These proteins also elicit immune responses that prevent infection or independently reduce viral replication
  • The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin
  • The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.